GSK, which has had a presence in India for 90 years, is keen to secure a bigger share of India’s growing $14 billion-a-year market. Photograph: Reuters/Toby Melville

GlaxoSmithKline said yesterday it had paid 64 billion rupees ($1.05 billion) to increase its stake in its Indian pharmaceuticals unit to 75 pe(...)

GSK, the UK-based pharmaceutical group, is to focus on products directly linked to healthcare. Photograph: Suzanne Plunkett/Reuters

Suntory of Japan is to pay £1.35 billion (€1.6 billion ) to buy GlaxoSmithKline’s high-profile consumer drinks brands Lucozade and Ribena. The deal(...)